Wyniki wyszukiwania - BazTech

Ograniczanie wyników

Znaleziono wyników: 2

Liczba wyników na stronie

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: gentamicin sulphate

Sortuj według:

Ogranicz wyniki do:

Gentamicin loaded PLGA nanoparticles as local drug delivery system for the osteomyelitis treatment

Posadowska U., Brzychczy-Włoch M., Pamuła E.

Acta of Bioengineering and Biomechanics

2015

Vol. 17, no. 3

41--48

Since there are more and more cases of multiresistance among microorganisms, rational use of antibiotics (especially their systemic vs. local application) is of great importance. Here we propose polymeric nanoparticles as locally applied gentamicin delivery system useful in osteomyelitis therapy. Gentamicin sulphate (GS) was encapsulated in the poly(lactide-co-glycolide) (PLGA 85:15) nanoparticles by double emulsification (water/oil/water, W1/O/W2). The nanoparticles were characterized by dynamic light scattering, laser electrophoresis and atomic force microscopy. UV-vis spectroscopy (O-phthaldialdehyde assay, OPA) and Kirby-Bauer tests were used to evaluate drug release and antimicrobial activity, respectively. Physicochemical characterization showed that size, shape and drug solubilization of the nanoparticles mainly depended on GS content and concentration of surface stabilizer (polyvinyl alcohol, PVA). Laser electrophoresis demonstrated negative value of zeta potential of the nanoparticles attributed to PLGA carboxyl end group presence. Drug release studies showed initial burst release followed by prolonged 35-day sustained gentamicin delivery. Agar-diffusion tests performed with pathogens causing osteomyelitis (Staphylococcus aureus and Staphylococcus epidermidis, both reference strains and clinical isolates) showed antibacterial activity of GS loaded nanoparticles (GS-NPs). It can be concluded that GS-NPs are a promising form of biomaterials useful in osteomyelitis therapy.

Fibrous systems with programmed biological-activity and their application in medical practice

Skundric P., Medovic A., Kostic M.

Autex Research Journal

2002

Vol. 2, no. 2

78--84

An effective two-stage method for obtaining both biologically activated fibres with antibacterial and anaesthetic activity and biologically activated complex fibres -insulin as an artificial store of insulin has been developed. The first stage involves the formation of reactive functional groups by chemical modification, followed by the second stage where the fibres are modified with chemotherapeutic agent solutions. This paper presents the results of obtaining biologically activated fibres with antibacterial and anaesthetic activity as well as an artificial store of insulin in the form of complex ion-exchanged fibre-insulin. The level of immobilisation of the drug in the antibacterial fibre amounts to 140 mg of gentamicin sulphate per 1 g of fibres, in the anaesthetic fibre 180 mg of procaine hydrochloride per 1 g of fibres, and in the fibrous store of insulin 800 mg of insulin per 1 g of fibres.